论文部分内容阅读
目的:观察辛散温化法治疗慢性阻塞性肺疾病急性加重期临床疗效。方法:将300例慢性阻塞性肺疾病急性加重期患者随机分为2组各150例。对照组应用抗生素、激素、平喘药物配合吸氧治疗;治疗组在对照组基础上加用小青龙汤。并予小青龙汤超声雾化吸入。疗程均为14天。结果:总有效率治疗组90.0%,对照组80.0%,2组比较,差异有统计学意义(P<0.05),治疗组疗效明显优于对照组。2组咳嗽、咳痰量、气喘、肺部啰音治疗前后比较,差异均有统计学意义(P<0.05);治疗后,治疗组各项指标与对照组比较,差异均有统计学意义(P<0.05)。结论:辛散温化法治疗慢性阻塞性肺疾病急性加重期临床疗效好,并可显著改善临床症状。
Objective: To observe the clinical efficacy of Xinsan warming therapy in treating acute exacerbation of chronic obstructive pulmonary disease. Methods: 300 patients with acute exacerbation of chronic obstructive pulmonary disease were randomly divided into two groups of 150 cases. The control group was treated with antibiotics, hormones and antiasthmatic drugs in combination with oxygen therapy. The treatment group was treated with Xiaoqinglong Decoction on the basis of the control group. And small dragon soup ultrasonic atomization inhalation. Treatment are 14 days. Results: The total effective rate was 90.0% in the treatment group and 80.0% in the control group. There was significant difference between the two groups (P <0.05). The curative effect of the treatment group was obviously better than that of the control group. There were significant differences between the two groups in cough, sputum volume, asthma, and pulmonary rales before and after treatment (P <0.05). After treatment, the indexes in the treatment group were significantly different from those in the control group P <0.05). Conclusion: Xinsan warming method in the treatment of chronic obstructive pulmonary disease in acute exacerbation clinical efficacy, and can significantly improve the clinical symptoms.